Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Donald B. Kohn, MD
Researcher Distinguished Professor
University of California, Los Angeles
Box 957357
Los Angeles, California, United States
Dr. Donald Kohn, MD, is a Distinguished Professor of pediatrics and microbiology, immunology and molecular genetics in the life sciences. Dr. Kohn was recruited to the UCLA faculty in 2009 from Childrens Hospital Los Angeles, where he served as an attending physician in the pediatric bone marrow transplant program for more than 20 years.
Dr. Donald Kohn, MD, focuses on the development of new methods to treat genetic diseases of blood cells, such as sickle cell and “bubble baby” disease, as well as using genetic modification of blood stem cells to treat cancer and leukemia. Kohn’s lab studies methods for effective gene transfer and expression and has translated those findings from the lab into clinical trials of gene therapy for congenital immune deficiencies and pediatric AIDS. A trial for sickle cell disease is currently under development.
In addition to being a member of the Broad Stem Cell Research Center, Dr. Kohn directs the Human Gene Medicine Program at UCLA and is a member of UCLA’s Jonsson Comprehensive Cancer Center. He also served as president of the American Society of Gene Therapy from 2003 to 2004, and currently is on the Board of Councilors for the Clinical Immunology Society.
+myBinderRelated Content
-
Richard Lottenberg, MDDr. Richard Lottenberg is a faculty memb...
-
Melissa Claar, MA, RN, CPNPNurse Practitioner Melissa Claar, MA, RN...
-
IASCNAPA Sickle Cell Disease Conference: Treating the Whole PersonDate: April 14-15, 2021 Place: Online/V...
-
Sickle cell patients in UK survey, especially those 16 to 20, voice problems with care and pain relief givenIn a survey, patients across the...
-
Patient controlled analgesia for adults with sickle cell disease awaiting admission from the emergency departmentBackground: A treatment algorithm for s...
-
Southeast Alabama Sickle Cell AssociationThe Southeast Alabama Sickle Cell Associ...
-
Decreased hospital readmissions for vaso occlusive crisis with implementation of a Sickle Cell Pain Action Plan (SPA...Vaso occlusive crisis (VOC) is the most ...
